Eleonora Nicolò

Weill Cornell Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (5)

Carolina Reduzzi

Assistant Professor

Weill Cornell Medicine

UNITED STATES

View details

Laura Boldrini

European Institute of Oncology

ITALY

View details

Paolo Tarantino

Dana-Farber Cancer Institute

UNITED STATES

View details

Luca Boscolo Bielo

European Institute of Oncology

ITALY

View details

Mohamed Gouda

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eleonora Nicolò

Research Interests

Explore related searches

Contact this professor

Articles (10)

Cancer in a drop: Liquid biopsy highlights from San Antonio Breast Cancer Symposium (SABCS) 2024

Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates

Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer.

Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study.

Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study.

Adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: one fits all?

Germline BRCA pathogenic variants in patients with ovarian cancer and post-poly (ADP-ribose) polymerase inhibitor myeloid neoplasms

Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors.

Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine.

Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials.

Collaborators (5)

Carolina Reduzzi

Laura Boldrini

Paolo Tarantino

Luca Boscolo Bielo

Mohamed Gouda

Make your next move.